SCHEMBL19786799

SCHEMBL19786799

C#CCCCCC(=O)NC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.54
CYP2D6 P10635 2/20 0.54
MAPT P10636 2/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
HSD17B10 Q99714 1/20 0.54
CYP3A4 P08684 2/20 0.44
LMNA P02545 1/20 0.41
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
MCL1 Q07820 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
HSP90AA1 P07900 1/20 0.34
SELP P16109 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15268183 0.98 CYP1A2 (0.57) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL29922517 0.98 CYP1A2 (0.57) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL3084079 0.93
SCHEMBL234815 0.84
SCHEMBL27414523 0.83 CYP1A2 (0.42) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL7753090 0.81 LMNA (0.57) LMNAALDH1A1KDM4EMCL1HDAC3
SCHEMBL27671650 0.80 HDAC1 (0.61) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL22081204 0.78 CYP1A2 (0.54) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL31097901 0.78 HDAC8 (0.65) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL7061135 0.78 LMNA (0.41) CYP1A2CYP2D6MAPTCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018013999-A1 NON-NUCLEOSIDIC SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE SYNTHESIS AM CHEMICALS LLC (US) 2018-01-18 WO disclosed